Ana M. Popa

Bucharest, B 010041, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pan-continental assessment of socioeconomic and environmental predictors of PFAS occurrence in European rivers from a harmonised monitoring study.

Pan-continental assessment of socioeconomic and environmental predictors of PFAS occurrence in European rivers from a harmonised monitoring study.

Journal: Water research

Published: March 20, 2026

Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.

Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.

Journal: Cureus

Published: February 17, 2025

The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.

The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.

Journal: Chirurgia (Bucharest, Romania : 1990)

Published: December 01, 2024

Prognostic and Predictive Determinants of Colorectal Cancer: A Comprehensive Review.

Prognostic and Predictive Determinants of Colorectal Cancer: A Comprehensive Review.

Journal: Cancers

Published: November 06, 2024

The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer.

The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer.

Journal: Medicina (Kaunas, Lithuania)

Published: June 28, 2024

Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.

Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.

Journal: Cureus

Published: December 18, 2023

The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.

The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.

Journal: International journal of molecular sciences

Published: September 29, 2023

Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review.

Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review.

Journal: Medicina (Kaunas, Lithuania)

Published: March 16, 2023

Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?

Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?

Journal: Diagnostics (Basel, Switzerland)

Published: March 01, 2023

Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature.

Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature.

Journal: Diagnostics (Basel, Switzerland)

Published: February 09, 2023

Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy.

Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy.

Journal: Cureus

Published: October 29, 2022

Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors-A Systematic Review of the Literature.

Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors-A Systematic Review of the Literature.

Journal: Current oncology (Toronto, Ont.)

Published: October 24, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026